Oct 16, 2018 ... STATE OF MINNESOTA, BY ITS ATTORNEY GENERAL LORI SWANSON v. SANOFI-AVENTIS U.S. LLC et al ...
May 16, 2016 ... Eisai v Sanofi-Aventis: Third Circuit Leaves Door Open to Loyalty ... have threatened to terminate supply if customers didn't meet all (or most) of ...
Feb 27, 2012 ... EEOC v. Picture People, Inc., 684 F.3d 981, 989 (10th Cir. 2012); Furr v. ... Age Discrimination in Employment Act, (the "ADEA"), 29 U.S.C. § 621, et seq. ... At all material times, sanofi-aventis was an "employer" as defined by ...
Jan 10, 2017 ... ... STATES OF AMERICA ex rel. YOASH GOHIL v. AVENTIS PHARMACEUTICALS, INC. et al. ... SANOFI-AVENTIS U.S. INC., Defendant
Amgen Inc. v. Sanofi. Petition for certiorari denied on January 7, 2019 ... Nov 19 2018, Brief of respondents Sanofi, et al. in opposition filed. Dec 04 2018, Reply ...
May 4, 2018 ... Adams, Lucy v. Sanofi US LLC, et al.1. 2:17-cv-15207. Agnew, Earlene v. Sanofi SA, et al. 2:18-cv-01306. Aldridge, Adele v. Sanofi SA, et al.
Nov 19, 2013 ... Meghann McManus, DO,1 Haydar Frangoul, MD,2 Jonathan A. McCullers, MD,3, 4 Li ... A recent study by Tasian et al. reported results from a five-year ... All subjects received either the SD TIV (Fluzone, Sanofi Pasteur) or HD TIV .... two doses of the vaccine (SD TIV, one dose: 94% and two doses: 100% vs.
All acute coronary syndrome events were assigned to 1 of 3 categories using pre -established criteria: ... (New vs. No), Pre-existing. AF (n=4494), P Value (Pre vs. No), No AF ..... This work was supported by an unrestricted grant from Sanofi Aventis to the Center for Outcomes ... Saczynski JS, McManus D, Zhou Z, et al.
2013; Wethmar 2014; Hinnebusch et al. ... 2009; Wethmar 2014; Chew et al. .... to Ribo-seq data from S. cerevisiae and S. paradoxus (McManus et al. ..... Haas BJ, Mertins P, Raychowdhury R, Hacohen N, Carr SA, Ingolia NT, et al. .... [PubMed]; Starck SR, Jiang V, Pavon-Eternod M, Prasad S, McCarthy B, Pan T, Shastri N.